Chris Butler

Stocks in Review: Union Pacific Corporation (UNP), Franklin Resources, Inc. (BEN), Deere & Company (DE)

Union Pacific Corporation (UNP) traded within a range of $107.71 to $108.49 after opening the day at $107.88. The company has seen its stock increase in value by 4.04% so far this year. The stock was up close to 0.42% on light volume in last trading session and closed at $107.87 per share. After the recent gain, the stock is currently holding -3.15% below its 52 week high of $111.38 and 50.34% above its 12-month low of $76.9. The shares are up by over 15.5% in the last three months, and the RSI indicator value of 55.12 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal, petroleum coke, and biomass; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export container traffic. Its rail network includes 32,070 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.

Franklin Resources, Inc. (BEN) continued its upward trend with the stock climbing 0.99% or $0.4 to close the day at $40.88 on active trading volume of 2.77M shares, compared to its three month average trading volume of 2.71M. The San Mateo California 94403 based company has been outperforming the asset management group over the past 52 weeks, with the stock gaining 32.71%, compared to the industry which has advanced 39.46% over the same period. With RSI of 56.22, the stock should still continue to rise and get closer to its one year target estimate of $38.91, making it a hold for now.

Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.

Deere & Company (DE) gained $1.12 to close the day at a new closing price of $110.24, a 1.03% increase in value from its previous closing price that moved the stock 50.8% above its 52 week low of $74.91. A total of 2.76M shares exchanged hands during the day compared with its three month average trading volume of 2.96M. The stock, which fluctuated between $109.15 and $110.39 during the day, currently situated 0.96% above its 52 week high. The stock is up by 4.29% in the past one month and up by 23.05% over the past three months. With a one year target estimate of $102.63 and RSI of 72.25, the stock still has upside potential, making it a sell for now.

Deere & Company, together with its subsidiaries, manufactures and distributes agriculture and turf, and construction and forestry equipment worldwide. The company’s Agriculture and Turf segment provides agriculture and turf equipment, and related service parts, including large, medium, and utility tractors; loaders; combines, cotton pickers and strippers, and sugarcane harvesters; related front-end harvesting equipment; sugarcane loaders and pull-behind scrapers; and tillage, seeding, and application equipment, including sprayers, nutrient management, and soil preparation machinery. This segment also provides hay and forage equipment comprising self-propelled forage harvesters and attachments, balers, and mowers; turf and utility equipment, including riding lawn equipment and walk-behind mowers, golf course equipment, utility vehicles, and commercial mowing equipment, as well as associated implements; integrated agricultural management systems technology and solutions; and other outdoor power products. Its Construction and Forestry segment provides backhoe loaders; crawler dozers and loaders; four-wheel-drive loaders; excavators; motor graders; articulated dump trucks; landscape loaders; skid-steer loaders; and log skidders, feller bunchers, log loaders, log forwarders, log harvesters, and related attachments that are used in construction, earthmoving, material handling, and timber harvesting applications. The company’s Financial Services segment finances sales and leases of new and used agriculture and turf equipment, and construction and forestry equipment. This segment also provides wholesale financing to dealers of the foregoing equipment; finances retail revolving charge accounts; and offers extended equipment warranties. The company markets its products primarily through independent retail dealer networks and retail outlets. Deere & Company was founded in 1837 and is headquartered in Moline, Illinois.

 

Trader’s Buzzers: Best Buy Co., Inc. (BBY), American Electric Power Company, Inc. (AEP), Amazon.com, Inc. (AMZN)

Best Buy Co., Inc. (BBY) traded within a range of $44.31 to $45 after opening the day at $44.96. The company has seen its stock increase in value by 4.71% so far this year. The stock was down close to -0.11% on light volume in last trading session and closed at $44.68 per share. After the recent fall, the stock is currently holding -9.55% below its 52 week high of $49.4 and 79.04% above its 12-month low of $28.02. The shares are up by over 16.72% in the last three months, and the RSI indicator value of 49.57 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Best Buy Co., Inc. operates as a retailer of technology products, services, and solutions in the United States, Canada, and Mexico. The company operates through two reportable segments, Domestic and International. Its stores provide consumer electronics, such as home theater, home automation, digital imaging, health and fitness, and portable audio products; computing and mobile phones, including computing and peripherals, networking, tablets, smart watches, and e-readers, as well as mobile phones comprising related mobile network carrier commissions; and entertainment products, such as gaming hardware and software, movie, music, technology toy, and other software products. The company’s stores also offer appliances, which include refrigeration and laundry appliances, dishwashers, ovens, coffee makers, blenders, etc.; and other products comprising snacks, beverages, and other sundry items. In addition, it provides services, such as consultation, design, delivery, installation, set-up, protection plan, repair, technical support, and educational services. The company offers its products through stores and Websites under the Best Buy, bestbuy.com, Best Buy Mobile, Best Buy Direct, Best Buy Express, Geek Squad, Magnolia Home Theater, Pacific Kitchen and Home, bestbuy.com.ca, bestbuy.com.mx, and Geek Squad brand names, as well as through call centers. As of January 30, 2016, it had approximately 1,200 large-format and 400 small-format stores. The company was formerly known as Sound of Music, Inc. Best Buy Co., Inc. was founded in 1966 and is headquartered in Richfield, Minnesota.

American Electric Power Company, Inc. (AEP) managed to rebound with the stock climbing 0.84% or $0.53 to close the day at $63.95 on light trading volume of 2.43M shares, compared to its three month average trading volume of 2.53M. The Columbus Ohio 43215 based company has been outperforming the electric utilities group over the past 52 weeks, with the stock gaining 8.08%, compared to the industry which has advanced 10.83% over the same period. With RSI of 61.5, the stock should still continue to rise and get closer to its one year target estimate of $67.03, making it a hold for now.

American Electric Power Company, Inc., a public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers. The company generates electricity using coal and lignite, natural gas, nuclear, and hydroelectric and other energy sources. It also supplies and markets electric power at wholesale to other electric utility companies, rural electric cooperatives, municipalities, and other market participants. The company delivers electricity to approximately 5.4 million customers in 11 states. The company owns and leases approximately 4,838 railcars, 498 barges, 12 towboats, 8 harbor boats, and a coal handling terminal. American Electric Power Company, Inc. was founded in 1906 and is headquartered in Columbus, Ohio.

Amazon.com, Inc. (AMZN) gained $6.1 to close the day at a new closing price of $827.46, a 0.74% increase in value from its previous closing price that moved the stock 70.96% above its 52 week low of $511.66. A total of 2.43M shares exchanged hands during the day compared with its three month average trading volume of 4.03M. The stock, which fluctuated between $822.85 and $828 during the day, currently situated -2.33% below its 52 week high. The stock is up by 3.56% in the past one month and up by 7.2% over the past three months. With a one year target estimate of $926.38 and RSI of 59, the stock still has upside potential, making it a hold for now.

Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions in North America and internationally. It operates through the North America, International, and Amazon Web Services (AWS) segments. The company sells merchandise and content purchased for resale from vendors, as well as those offered by third-party sellers through retail Websites, such as amazon.com, amazon.ca, amazon.com.mx, amazon.com.au, amazon.com.br, amazon.cn, amazon.fr, amazon.de, amazon.in, amazon.it, amazon.co.jp, amazon.nl, amazon.es, and amazon.co.uk. It also manufactures and sells electronic devices, including kindle e-readers, fire tablets, fire TVs, and echo; and provides Kindle Direct Publishing, an online service that allows independent authors and publishers to make their books available in the Kindle Store. In addition, the company offers programs that enable sellers to sell their products on its Websites, as well as their own branded Websites; and programs that allow authors, musicians, filmmakers, app developers, and others to publish and sell content. Further, it provides compute, storage, database, and other AWS services, as well as fulfillment, publishing, digital content subscriptions, advertising, and co-branded credit card agreements services. Additionally, the company offers Amazon Prime, an annual membership program, which provides free shipping of various items; access to unlimited streaming of movies and TV episodes; and other services. It serves consumers, sellers, developers, enterprises, and content creators. The company was founded in 1994 and is headquartered in Seattle, Washington.

 

Stocks Under Consideration: Tesoro Corporation (TSO), The Hartford Financial Services Group, Inc. (HIG), General Mills, Inc. (GIS)

Tesoro Corporation (TSO) retreated with the stock falling -0.29% or $-0.25 to close at $87.33 on light trading volume of 1.99M compared its three months average trading volume of 2.63M. The San Antonio Texas 78259 based company operating under the Oil & Gas Refining & Marketing industry has been trending up for the last 52 weeks, with the shares price now 24.54% up for the period and down by -0.14% so far this year. With price target of $105.63 and a 32.27% rebound from 52-week low, Tesoro Corporation has plenty of upside potential, making it a hold with a view buy.

Tesoro Corporation, through its subsidiaries, operates as an independent petroleum refining, logistics, and marketing company in the United States. Its Refining segment refines crude oil and other feed stocks into transportation fuels, such as gasoline, gasoline blend stocks, jet fuel, and diesel fuel, as well as other products, including heavy fuel oils, liquefied petroleum gas, petroleum coke, calcined coke, and asphalt. This segment also sells refined products in the wholesale market primarily through independent unbranded distributors; and in the bulk market primarily to independent unbranded distributors, other refining and marketing companies, utilities, railroads, airlines, marine, and industrial end-users in the western United States. It owns and operates 6 refineries with a combined crude oil capacity of approximately 875 thousand barrels per day. The company’s TLLP segment owns and operates a network of approximately 3,500 miles of crude oil, refined products, and natural gas pipelines; 29 crude oil and refined products truck and marine terminals; and approximately 15 million barrels of storage capacity. This segment also owns and operates four natural gas processing complexes and one fractionation facility. The company’s Marketing segment sells gasoline and diesel fuel through retail stations, and third-party branded dealers and distributors in the western United States. As of December 31, 2015, this segment operated a network of 2,397 retail stations under the ARCO, Shell, Exxon, Mobil, USA Gasoline, and Tesoro brands. The company was formerly known as Tesoro Petroleum Corporation and changed its name to Tesoro Corporation in November 2004. Tesoro Corporation was founded in 1968 and is headquartered in San Antonio, Texas.

The Hartford Financial Services Group, Inc. (HIG) had a light trading with around 1.99M shares changing hands compared to its three month average trading volume of 2.52M. The stock traded between $47.45 and $47.87 before closing at the price of $47.86 with 0.67% change on the day. The Hartford Connecticut 06155 based company is currently trading 27.17% above its 52 week low of $38.92 and -3.66% below its 52 week high of $49.68. Both the RSI indicator and target price of  and $52.42 respectively, lead us to believe that it could rise over the coming weeks.

The Hartford Financial Services Group, Inc., through its subsidiaries, provides insurance and financial services to individual and business customers in the United States. It operates through six segments: Commercial Lines, Personal Lines, Property & Casualty Other Operations, Group Benefits, Mutual Funds, and Talcott Resolution. The Commercial Lines segment offers workers’ compensation, property, automobile, liability, umbrella, marine, and livestock insurance, as well as customized insurance products and services, including general liability, professional liability, bond, and specialty casualty coverages. The Personal Lines segment provides automobile, homeowners, and personal umbrella coverages to individuals. The Property & Casualty Other Operations segment manages property and casualty insurance. The Group Benefits segment offers group life, accident and disability coverage, and group retiree health to employer groups, associations, and affinity groups; and disability underwriting, administration, claims processing, and reinsurance to other insurers and self-funded employer plans. The Mutual Funds segment provides investment products for retail and retirement accounts; and investment-management and administrative services, such as product design, implementation, and oversight, as well as the runoff of the mutual funds supporting the company’s variable annuity products. The Talcott Resolution segment engages in the U.S. annuity, institutional, and private-placement life insurance businesses. It has a research partnership with UCLA Anderson Forecast to understand the critical economic issue and other trends affecting small business. The Hartford Financial Services Group, Inc. was founded in 1810 and is headquartered in Hartford, Connecticut.

General Mills, Inc. (GIS) saw its value decrease by -0.48% as the stock dropped $-0.3 to finish the day at a closing price of $62.76. The stock was lighter in trading and has fluctuated between $56.34-$72.95 per share for the past year. The shares, which traded within a range of $62.63 to $63.33 during the day, are up by 0.81% in the past three months and down by -10.32% over the past six months. It is currently trading 0.97% above its 20 day moving average and 1.45% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $63.6 a share over the next twelve months. The current relative strength index (RSI) reading is 53.44.The technical indicator lead us to believe there will be no major movement any time soon, hold.

General Mills, Inc. manufactures and markets branded consumer foods in the United States. It operates in three segments: U.S. Retail, International, and Convenience Stores and Foodservice. The company offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, frozen pizza and pizza snacks, grain and fruit and savory snacks, stable and frozen vegetables, and ice cream and frozen desserts, as well as various organic products, including meal kits, granola bars, and cereal. The company markets its products under the Annie’s, Betty Crocker, Bisquick, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto’s, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jeno’s, Jus-Rol, Kitano, Kix, La Salteña, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino’s, Trix, Wanchai Ferry, Wheaties, Yoki, and Yoplait names. General Mills, Inc. also supplies branded and unbranded food products to the foodservice and commercial baking industries. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce grocery providers, commercial and noncommercial foodservice distributors and operators, restaurants, and convenience stores, as well as drug, dollar, and discount chains. The company operates 530 ice cream parlors; and franchises 344 branded ice cream parlors. General Mills, Inc. also exports its products primarily to Caribbean and Latin American markets. The company was founded in 1928 and is headquartered in Minneapolis, Minnesota.

 

3 Stocks in Focus: Conagra Brands, Inc. (CAG), Analog Devices, Inc. (ADI), Alexion Pharmaceuticals, Inc. (ALXN)

Conagra Brands, Inc. (CAG) climbed 0.28% during last trading as the stock added $0.11 to finish the day at $39.84 with about 1.68M shares changing hands, compared to its three month average trading volume of 3.44M. The $17.29B market cap company, which fluctuated between $39.27 and $39.99 during the day, currently situated 32.4% above its 52 week low of $32.03 and -0.4% away from its one year high of $40. The RSI of 66.79 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Conagra Brands, Inc., together with its subsidiaries, operates as a food company in North America. It operates through five segments: Grocery & Snacks, Refrigerated & Frozen, International, Foodservice, and Commercial. The Grocery & Snacks segment primarily provides branded, shelf-stable food products in various retail channels in the United States. The Refrigerated & Frozen segment offers branded, temperature controlled food products in various retail channels in the United States. The International segment primarily provides branded food products, in various temperature states, in retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, such as meals, entrees, prepared potatoes, sauces, and various custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The Commercial segment offers commercially branded and private label food and ingredients primarily to commercial, restaurant, foodservice, food manufacturing, and industrial customers. The company markets its products primarily under the Healthy Choice, Hunt’s, Slim Jim, Reddi-wip, Alexia, Blake’s, Frontera, Bertolli, P.F. Chang’s, and Marie Callender’s brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.

Analog Devices, Inc. (ADI) gained $0.02 to close the day at a new closing price of $76.53, a 0.03% increase in value from its previous closing price that moved the stock 63.34% above its 52 week low of $49.79. A total of 1.67M shares exchanged hands during the day compared with its three month average trading volume of 2.63M. The stock, which fluctuated between $75.54 and $76.78 during the day, currently situated -1.59% below its 52 week high. The stock is up by 5.38% in the past one month and up by 18.46% over the past three months. With a one year target estimate of $79.58 and RSI of 60.02, the stock still has upside potential, making it a hold for now.

Analog Devices, Inc. designs, manufactures, and markets a portfolio of solutions that leverage analog, mixed-signal, and digital signal processing technology, including integrated circuits (ICs), algorithms, software, and subsystems. It offers data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; high-performance amplifiers to condition analog signals; and radio frequency ICs to support cellular infrastructure. The company also provides MEMS technology solutions, including accelerometers used to sense acceleration, gyroscopes to sense rotation, and inertial measurement units to sense multiple degrees of freedom. In addition, it offers isolators for various applications, such as universal serial bus isolation in patient monitors; and smart metering and satellite applications. Further, the company provides power management and reference products; and digital signal processing products for high-speed numeric calculations. Its products are used in electronic equipment, including industrial process control systems, medical imaging equipment, factory automation systems, patient monitoring devices, instrumentation and measurement systems, wireless infrastructure equipment, energy management systems, networking equipment, aerospace and defense electronics, optical systems, automobiles, and portable electronic devices. The company serves clients in industrial, automotive, consumer, and communications markets through a direct sales force, third-party distributors, and independent sales representatives in the United States, rest of North/South America, Europe, Japan, China, and rest of Asia, as well as through its Website. It has a collaboration with TriLumina Corp. to provide illuminator modules for automotive flash LiDAR systems. Analog Devices, Inc. was founded in 1965 and is headquartered in Norwood, Massachusetts.

Alexion Pharmaceuticals, Inc. (ALXN) had a light trading with around 1.67M shares changing hands compared to its three month average trading volume of 2.87M. The stock traded between $125.85 and $127.98 before closing at the price of $126.51 with -0.45% change on the day. The New Haven Connecticut 06510 based company is currently trading 15.94% above its 52 week low of $109.12 and -21.91% below its 52 week high of $162. Both the RSI indicator and target price of 46.21 and $167.93 respectively, lead us to believe that it should be put on hold over the coming weeks.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia (HPP); and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH registry; Phase III clinical trials for the treatment of myasthenia gravis, neuromyelitis optica spectrum disorder, and delayed kidney transplant graft function; and Phase II clinical trials for antibody mediated rejection in presensitized renal transplant patients. It develops cPMP (ALXN 1101) that is in Phase II/III trial for treating metabolic disorders; and ALXN 1007, a novel humanized antibody in Phase II clinical trial for the treatment of anti-phospholipid syndrome and graft versus host disease. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other health care providers, as well as governments and government agencies in the United States, Europe, the Asia Pacific, and internationally. Alexion Pharmaceuticals, Inc. has agreements with X-Chem Pharmaceuticals (X-Chem) to identify novel drug candidates from X-Chem’s proprietary drug discovery engine; Moderna Therapeutics, Inc. (Moderna) that provides the option to purchase drug products for clinical development commercialization of Moderna’s messenger RNA therapeutics to treat rare diseases; and Ensemble Therapeutics Corporation for the identification, development, and commercialization of therapeutic candidates based on specific drug targets. The company was founded in 1992 and is headquartered in New Haven, Connecticut.

 

Eye Catching Stocks: WestRock Company (WRK), Baxter International Inc. (BAX), 3M Company (MMM)

WestRock Company (WRK) managed to rebound with the stock climbing 0.32% or $0.17 to close the day at $52.48 on light trading volume of 1.41M shares, compared to its three month average trading volume of 1.57M. The Richmond Virginia 23219 based company has been outperforming the packaging & containers group over the past 52 weeks, with the stock gaining 81.26%, compared to the industry which has advanced 41.07% over the same period. With RSI of 48.74, the stock should still continue to rise and get closer to its one year target estimate of $57.27, making it a hold for now.

WestRock Company manufactures and sells paper and packaging solutions for the consumer and corrugated markets in North America, South America, Europe, and Asia. The company operates through Corrugated Packaging, Consumer Packaging, and Land and Development segments. The Corrugated Packaging segment produces containerboards, corrugated sheets, corrugated packaging, and preprinted linerboards for consumer and industrial products manufacturers, and corrugated box manufacturers; and recycled fiber. This segment also provides structural and graphic design, engineering services, and automated packaging machines; resells aluminum and plastics; and offers waste services. Its corrugated packaging products are used to provide protective packaging for the shipment and distribution of food, paper, health and beauty, other household, consumer, commercial, and industrial products. The Consumer Packaging segment manufactures and sells folding and beverage cartons, displays, dispensing, and interior partitions; paperboards; recycled paperboards; express mail envelopes for the overnight courier industry; and secondary packages and paperboard packaging for the healthcare market. This segment also manufactures and sells solid fiber and corrugated partitions and die-cut paperboard components; temporary and permanent point-of-purchase displays for the consumer products and retail markets; dispensing systems, such as pumps; lithographic laminated packaging products; flip-top and applicator closures; plastic packaging products; trigger sprayers; aerosol actuators; hose-end sprayers; spouted and applicator closures; and sprayers for nasal and throat applications, as well as provides contract packing services. The company’s Land and Development segment engages in real estate development activities. WestRock Company is based in Richmond, Virginia.

Baxter International Inc. (BAX) climbed 0.14% during last trading as the stock added $0.07 to finish the day at $49 with about 1.4M shares changing hands, compared to its three month average trading volume of 3.45M. The $26.61B market cap company, which fluctuated between $48.77 and $49.13 during the day, currently situated 38.7% above its 52 week low of $36.67 and -2.03% away from its one year high of $50.16. The RSI of 72.91 indicates the stock is overbought at the current levels, sell for now.

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis (HD), home HD, continuous renal replacement therapy, and additional dialysis services. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and by patients at home under physician supervision. Baxter International Inc. offers its products through direct sales force, independent distributors or sales agents, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

3M Company (MMM) saw its value increase by 0.46% as the stock gained $0.82 to finish the day at a closing price of $179. The stock was lighter in trading and has fluctuated between $153.64-$182.27 per share for the past year. The shares, which traded within a range of $178.19 to $179.58 during the day, are up by 5.73% in the past three months and up by 0.15% over the past six months. It is currently trading 1.3% above its 20 day moving average and 1.28% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $187.73 a share over the next twelve months. The current relative strength index (RSI) reading is 59.36. The technical indicator lead us to believe there will be no major movement any time soon, hold.

3M Company operates as a diversified technology company worldwide. The company’s Industrial segment offers tapes; coated, non-woven, and bonded abrasives; adhesives; advanced ceramics; sealants; specialty materials; separation and purification products; closure systems for personal hygiene products; acoustic systems products; automotive components; and abrasion-resistant films, and paint finishing and detailing products. Its Safety and Graphics Business segment provides personal protection products, traffic safety and security products, commercial graphics systems, commercial cleaning and protection products, floor matting, roofing granules for asphalt shingles, and fall protection products. The company’s Health Care segment offers medical and surgical supplies, skin health and infection prevention products, inhalation and transdermal drug delivery systems, dental and orthodontic products, health information systems, and food safety products. Its Electronics and Energy segment provides optical films; packaging and interconnection devices; insulating and splicing solutions; touch screens and touch monitors; renewable energy component solutions; and infrastructure protection products. The company’s Consumer segment offers sponges, scouring pads, high-performance cloths, repositionable notes, indexing systems, home improvement and care products, protective materials, and consumer and office tapes and adhesives. The company serves automotive, electronics and energy, appliance, paper and printing, packaging, food and beverage, construction, medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, health information systems, food manufacturing and testing, consumer and office retail, office business to business, home improvement, drug and pharmacy retail, and other markets directly, as well as through wholesalers, retailers, jobbers, distributors, and dealers. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.

 

Stocks To Watch: Globalstar, Inc. (GSAT), Cobalt International Energy, Inc. (CIE), Rennova Health, Inc. (RNVA)

Globalstar, Inc. (GSAT) traded within a range of $1.34 to $1.43 after opening the day at $1.4. The company has seen its stock decrease in value by -14.56% so far this year. The stock was down close to -2.17% on light volume in last trading session and closed at $1.35 per share. After the recent fall, the stock is currently holding -55.% below its 52 week high of $3 and 114.29% above its 12-month low of $0.63. The shares are up by over 31.07% in the last three months, and the RSI indicator value of 46.73 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications; fixed voice and data satellite communications services and equipment in rural villages, ships, industrial and commercial sites, and residential sites; and satellite data modem services comprising asynchronous and packet data services. It also provides SPOT products, such as SPOT satellite GPS messenger for personal tracking, emergency location, and messaging solutions; SPOT Global phone; and SPOT Trace, an anti-theft and asset tracking device. In addition, the company offers commercial Simplex one-way transmission products to track cargo containers and rail cars, to monitor utility meters, to monitor oil and gas assets, and other applications. Further, it provides engineering services, such as hardware and software designs to develop specific applications; and installation of gateways and antennas. The company primarily serves recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining, and forestry; construction; utilities; and transportation markets. Globalstar, Inc. distributes its products directly, as well as through independent agents, dealers and resellers, independent gateway operators, and its sales force and e-commerce Website. As of December 31, 2015, it served approximately 688,000 subscribers. The company has a collaboration agreement with Carmanah to design and manufacture solar powered M2M satellite solutions. The company was founded in 2003 and is headquartered in Covington, Louisiana. Globalstar, Inc. is a subsidiary of Thermo Funding II LLC.

Cobalt International Energy, Inc. (CIE) failed to extend gains with the stock declining -0.93% or $-0.01 to close the day at $0.81 on active trading volume of 8.26M shares, compared to its three month average trading volume of 4.93M. The Houston Texas 77024 based company has been underperforming the independent oil & gas group over the past 52 weeks, with the stock losing -65.13%, compared to the industry which has advanced 58.11% over the same period. With RSI of 28.81, the stock should still continue to rise and get closer to its one year target estimate of $2.69, making it a hold for now.

Cobalt International Energy, Inc., through its subsidiaries, operates as an oil and gas exploration and production company primarily in the deepwater U.S. Gulf of Mexico. The company holds interests in the North Platte, Shenandoah, Anchor, and Heidelberg fields located in the U.S. Gulf of Mexico; and the Diaba block located offshore Gabon. As of December 31, 2015, it had net proved undeveloped reserves of 5.6 million barrels (MMBbls) of oil; 0.3 MMBbls of natural gas liquids; and 1.8 billion cubic feet of natural gas. The company was founded in 2005 and is based in Houston, Texas.

Rennova Health, Inc. (RNVA) dropped $0 to close the day at a new closing price of $0.06, a -2.47% decrease in value from its previous closing price that moved the stock 27.25% above its 52 week low of $0.05. A total of 6.67M shares exchanged hands during the day compared with its three month average trading volume of 8.56M. The stock, which fluctuated between $0.0521 and $0.064 during the day, currently situated -94.89% below its 52 week high. The stock is down by -47.52% in the past one month and down by -53.31% over the past three months. With a one year target estimate of $18.5 and RSI of 31.61, the stock still has upside potential, making it a hold for now.

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers in the United States. It offers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices. The company provides toxicology, clinical pharmacogenetics, and esoteric testing services; develops Web-based system to place lab orders, track samples, and view test reports in real time; Web-enabled laboratory information management solutions; Medical Mime, which offers an electronic health record for substance abuse and behavioral health providers; and CollabRx that enhances cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

 

Trader’s Round Up: Vista Outdoor Inc. (VSTO), Provectus Biopharmaceuticals, Inc. (PVCT), Peregrine Pharmaceuticals, Inc. (PPHM)

Vista Outdoor Inc. (VSTO) grew with the stock adding 3.01% or $0.63 to close at $21.58 on active trading volume of 4.1M compared its three months average trading volume of 1.34M. The Farmington Utah 84025 based company operating under the Sporting Goods industry has been trending down for the last 52 weeks, with the shares price now -52% down for the period and down by -41.52% so far this year. With price target of $33.25 and a 9.43% rebound from 52-week low, Vista Outdoor Inc. has plenty of upside potential, making it a hold with a view buy.

Vista Outdoor Inc. designs, manufactures, and markets consumer products for the outdoor sports and recreation markets worldwide. The company’s Shooting Sports segment designs, develops, produces, and sources ammunition for the hunting and sport shooting enthusiast markets, as well as for local law enforcement, the United States government, and international markets under the Federal Premium, Speer, American Eagle, Blazer, CCI, Estate Cartridge, Stevens, Fusion, Savage Arms, Savage Range Systems, Force on Force, and Independence brands; and provides firearms products, such as centerfire rifles, rimfire rifles, shotguns, and range systems. Its Outdoor Products segment offers archery/hunting accessories, such as hunting arrows, game calls, hunting blinds, game cameras, and waterfowl decoys; eyewear and sport protection products comprising safety and protective eyewear, fashion and sports eyewear, and helmets; golf products, including laser rangefinders; and hydration products consisting of hydration packs and water bottles. This segment also offers optics products, such as binoculars, riflescopes, and telescopes; shooting accessories, including reloading equipment, clay targets, and premium gun care products; tactical products comprising holsters, duty gear, bags, and packs; and water sports products, such as stand up paddle boards. It provides its products under the Alliant Powder, Bee Stinger, BLACKHAWK!, Bollé, Bushnell, Butler Creek, CamelBak, Cébé, Champion Target, Eagle, Final Approach, Gold Tip, GunMate, Gunslick Pro, Hoppe’s, Jimmy Styks, M-Pro 7, Millett, Night Optics, Outers, Primos, RCBS, Redfield, Serengeti, Simmons, Stoney Point, Tasco, Uncle Mike’s, and Weaver brand names. The company sells its products to outdoor enthusiasts, hunters and recreational shooters, athletes, and law enforcement and military professionals through various mass, specialty, and independent retailers. The company was incorporated in 2014 and is headquartered in Farmington, Utah.

Provectus Biopharmaceuticals, Inc. (PVCT) dropped $0 to close the day at a new closing price of $0.02, a -21.2% decrease in value from its previous closing price that moved the stock 55.45% above its 52 week low of $0.011. A total of 3.82M shares exchanged hands during the day compared with its three month average trading volume of 4.24M. The stock, which fluctuated between $0.017 and $0.0212 during the day, currently situated -96.82% below its 52 week high. The stock is up by 0.59% in the past one month and down by -70% over the past three months. With a one year target estimate of $3.5 and RSI of 49.91, the stock still has upside potential, making it a hold for now.

Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. Its prescription drug candidates includes PV-10, which is in Phase III study for cutaneous melanoma; completed Phase II study for metastatic melanoma; completed Phase I study for liver and breast cancers; and phase 1b/2 study for pembrolizumab. The company is also developing PH-10 that has completed Phase II randomized study for the treatment of psoriasis and atopic dermatitis. In addition, it develops PH-10 for the treatment of actinic keratosis and severe acne vulgaris. Further, the company is developing over-the-counter pharmaceuticals, including GloveAid, a hand cream with antiperspirant and antibacterial properties; Pure-ific line of products to prevent the spread of germs on skin; and Pure-Stick and Pure N Clear acne products. Additionally, it develops medical device technologies for markets comprising cosmetic treatments, such as reduction of wrinkles and elimination of spider veins, and other cosmetic blemishes; and therapeutic uses, including photoactivation of PH-10, other prescription drugs, and non-surgical destruction of various skin cancers. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee.

Peregrine Pharmaceuticals, Inc. (PPHM) shares were down in last trading by -0.42% to $0.36. It experienced higher than average volume on day. The stock increased in value by almost 13.79% over the past week and grew 22.93% in the past month. It is currently trading 14.41% above its 50 day moving average and -1.25% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -68.17% decrease in value from its one year high of $1.12. The RSI indicator value of 67.26, lead us to believe that it is a hold for now.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It’s lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy and related support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; Merck KGaA; and National Comprehensive Cancer Network, as well as collaboration agreement with AstraZeneca PLC and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.

 

Stocks To Track: Community Health Systems, Inc. (CYH), Sarepta Therapeutics, Inc. (SRPT), Gannett Co., Inc. (GCI)

Community Health Systems, Inc. (CYH) fell -2.09% during last trading as the stock lost $-0.14 to finish the day at $6.56 with about 2.08M shares changing hands, compared to its three month average trading volume of 3.43M. The $761.68M market cap company, which fluctuated between $6.54 and $6.83 during the day, currently situated 58.07% above its 52 week low of $4.15 and -69.32% away from its one year high of $21.38. The RSI of 53.58 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Community Health Systems, Inc., together with its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies. In addition, it offers management and consulting services to non-affiliated general acute care hospitals. As of February 15, 2016, the company owned, leased, or operated 195 affiliated hospitals in 29 states with approximately 30,000 licensed beds. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

Sarepta Therapeutics, Inc. (SRPT) dropped $-1.51 to close the day at a new closing price of $27.83, a -5.15% decrease in value from its previous closing price that moved the stock 247.87% above its 52 week low of $8. A total of 2.04M shares exchanged hands during the day compared with its three month average trading volume of 2.44M. The stock, which fluctuated between $27.83 and $29.44 during the day, currently situated -56.33% below its 52 week high. The stock is down by -21.72% in the past one month and down by -34.78% over the past three months. With a one year target estimate of $62.89 and RSI of 38.16, the stock still has upside potential, making it a hold for now.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. The company’s lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which is in Phase III clinical development for the treatment of individuals with Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease caused by the absence of dystrophin. It is also developing exon-skipping drugs for the treatment of DMD; and therapeutic candidates for the treatment of infectious diseases, such as influenza, Marburg, and Ebola. The company has a strategic alliance with Charley’s Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies; a license agreement with the University of Western Australia for the use of antisense sequences in the treatment of DMD; and a research collaboration agreement with Catabasis Pharmaceuticals, Inc to explore a combination drug treatment approach for DMD. It also has a research and option agreement with Nationwide Children’s Hospital for microdystrophin gene therapy program. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Gannett Co., Inc. (GCI) had a active trading with around 2.04M shares changing hands compared to its three month average trading volume of 1.06M. The stock traded between $8.84 and $9.14 before closing at the price of $8.94 with -1.22% change on the day. The McClean Virginia 22107 based company is currently trading 24.55% above its 52 week low of $7.3 and -47.45% below its 52 week high of $17.72. Both the RSI indicator and target price of 36.83 and $11 respectively, lead us to believe that it should be put on hold over the coming weeks.

Gannett Co., Inc. operates as a multi-platform news and information company. The company’s operations comprise USA TODAY, a newspaper in print and digital circulation; 92 daily local publications in the United States and Guam; approximately 400 non-daily publications in the United States; and approximately 150 local news brands online, mobile, and in print in the United Kingdom. It also provides commercial printing, marketing, and data services. The company was formerly known as Gannett SpinCo, Inc. and changed its name to Gannett Co., Inc. in May 2015. Gannett Co., Inc. was incorporated in 2014 and is based in McLean, Virginia.

 

Momentum Stocks: NextEra Energy, Inc. (NEE), The Travelers Companies, Inc. (TRV), DENTSPLY SIRONA Inc. (XRAY)

NextEra Energy, Inc. (NEE) grew with the stock adding 0.66% or $0.82 to close at $125.47 on light trading volume of 1.21M compared its three months average trading volume of 2.32M. The Juno Beach Florida 33408 based company operating under the Electric Utilities industry has been trending up for the last 52 weeks, with the shares price now 15.48% up for the period and up by 5.03% so far this year. With price target of $136.33 and a 17.3% rebound from 52-week low, NextEra Energy, Inc. has plenty of upside potential, making it a hold with a view buy.

NextEra Energy, Inc., through its subsidiaries, generates, transmits, and distributes electric energy in the United States and Canada. The company generates electricity from gas, oil, solar, coal, petroleum coke, nuclear, and wind sources. As of December 31, 2015, it served approximately 9.5 million people through approximately 4.8 million customer accounts in the east and lower west coasts of Florida. The company had approximately 46,400 megawatts of generating capacity. It also leases fiber-optic network capacity and dark fiber to telephone, wireless, and Internet companies. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. NextEra Energy, Inc. was founded in 1984 and is headquartered in Juno Beach, Florida.

The Travelers Companies, Inc. (TRV) had a light trading with around 1.2M shares changing hands compared to its three month average trading volume of 1.64M. The stock traded between $118.99 and $120.21 before closing at the price of $119.73 with 0.8% change on the day. The New York New York 10017 based company is currently trading 18.84% above its 52 week low of $103.45 and -2.73% below its 52 week high of $123.09. Both the RSI indicator and target price of  and $121.73 respectively, lead us to believe that it could rise over the coming weeks.

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally. The company operates in three segments: Business and International Insurance; Bond & Specialty Insurance; and Personal Insurance. The Business and International Insurance segment offers property and casualty products, including commercial multi-peril, commercial property, general liability, commercial automobile, and workers’ compensation; and personal property, employers’ liability, public and product liability, professional indemnity, commercial property, surety, marine, aviation, personal accident, and kidnap and ransom insurance. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; first party that provides traditional and customized property insurance programs to large and mid-sized customers; and specialized distribution, which markets and underwrites its products through brokers, wholesale agents, program managers, and specialized retail agents. The Bond & Specialty Insurance segment provides fidelity and surety, general liability, and others, such as property, workers’ compensation, commercial automobile, and commercial multi-peril insurance products. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals. The company distributes its products primarily through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

DENTSPLY SIRONA Inc. (XRAY) saw its value decrease by -0.38% as the stock dropped $-0.22 to finish the day at a closing price of $58.39. The stock was lighter in trading and has fluctuated between $54.05-$65.83 per share for the past year. The shares, which traded within a range of $58.26 to $58.75 during the day, are down by -4.45% in the past three months and down by -4.71% over the past six months. It is currently trading 2.68% above its 20 day moving average and 0.72% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $66.5 a share over the next twelve months. The current relative strength index (RSI) reading is 57.95.The technical indicator lead us to believe there will be no major movement any time soon, hold.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

 

Trader Alert: Exelixis, Inc. (EXEL), EnteroMedics Inc. (ETRM), Denbury Resources Inc. (DNR)

Exelixis, Inc. (EXEL) grew with the stock adding 4.12% or $0.89 to close at $22.5 on active trading volume of 8.09M compared its three months average trading volume of 5.95M. The South San Francisco California 94080 based company operating under the Biotechnology industry has been trending up for the last 52 weeks, with the shares price now 431.91% up for the period and up by 50.91% so far this year. With price target of $20.5 and a 533.8% rebound from 52-week low, Exelixis, Inc. has plenty of upside potential, making it a hold with a view buy.

Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. It focuses on advancing cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program. The company has received regulatory approval for two separate formulations of cabozantinib for the treatment of certain forms of kidney and thyroid cancer and marketed as CABOMETYX tablets in the United States and COMETRIQ capsules in the United States and European Union respectively. It also offers COTELLIC (cobimetinib), a selective inhibitor of MEK, in the United States and European Union; and is being evaluated for further potential indications by Roche and Genentech under collaboration with Exelixis. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

EnteroMedics Inc. (ETRM) gained $1.03 to close the day at a new closing price of $8.15, a 14.47% increase in value from its previous closing price that moved the stock 20275% above its 52 week low of $0.04. A total of 7.96M shares exchanged hands during the day compared with its three month average trading volume of 12.38M. The stock, which fluctuated between $7.63 and $8.52 during the day, currently situated -73.2% below its 52 week high. The stock is down by -70.58% in the past one month and up by 13282.59% over the past three months. With a one year target estimate of $140 and RSI of 53.46, the stock still has upside potential, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Denbury Resources Inc. (DNR) shares were up in last trading by 6.08% to $3.49. It experienced lighter than average volume on day. The stock increased in value by almost 2.65% over the past week and fell -5.42% in the past month. It is currently trading -5.73% below its 50 day moving average and 2.19% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -27.29% decrease in value from its one year high of $4.8. The RSI indicator value of 44.9, lead us to believe that it is a hold for now.

Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on enhanced oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. As of December 31, 2015, the company had 288.6 million barrels of oil equivalent of estimated proved oil and natural gas reserves. Denbury Resources Inc. was founded in 1951 and is headquartered in Plano, Texas.